EDUCATION :
B.Sc., Chemistry and Biology – University of California, Los Angeles, CA Magna Cum Laude and Departmental Honors
Medical Doctorate – UCLA School of Medicine, Los Angeles, CA
Internship, Internal Medicine – St. Mary Medical Center, Long Beach, CA
Residency, Radiation Oncology – UCLA Department of Radiation Oncology, Los Angeles, CA
PROFESSIONAL EXPERIENCE :
Radiation Oncologist – Palo Alto Medical Foundation Radiation Oncology Palo Alto, CA
Radiation Oncologist Medical Director – Swedish Cancer Institute at Northwest Hospital Seattle, W A
ACADEMIC APPOINTMENTS :
1990 – 2005 – Stanford University Department of Radiation Oncology Adjunct Clinical Assistant Professor
BOARD CERTIFICATION :
American Board of Radiology, Radiation Oncology National Board of Medical Examiners
RESEARCH GRANTS :
National Principal Investigator, CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution. An on-going multi-institutional study; ClinicalTrials.gov Identifier: NCT00643994
PUBLICATIONS:
First Author
Meier R, Kaplan I et al. Patient-Reported Quality of Life Outcomes in Intermediate-Risk Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy. Intern J Radiat Oncol Biol Phys 87(2): S25, 2013
Meier R, Kaplan I et al. Stereotactic Body Radiation Therapy for Intermediate-risk Organ- confined Prostate Cancer: Interim Toxicity and Quality of Life Outcomes from a Multi- Institutional Study Intern J Radiat Oncol Biol Phys 84(3): S148, 2012
Meier R, Kaplan I et al. Long-term Outcomes of Stereotactic Body Radiation Therapy for Organ-confined Prostate Cancer confined Prostate Cancer. Intern J Radiat Oncol Biol Phys 84(3): S417, 2012
Meier R, Beckman A et al. Stereotactic Radiotherapy for Organ-confined Prostate Cancer: Early Toxicity and Quality of Life Outcomes from a Multi-institutional Trial. Intern J Radiat Oncol Biol Phys 78(3): S57, 2010
Meier R, Sanda M, Kaplan I. Robotic Radiosurgery for Organ-confined Prostate Cancer: Early Toxicity Outcomes from a Multi-institutional Trial. J Urology 183(4): e785, 2010
Meier R, Cotrutz C. MRI-planned Stereotactic Body Radiotherapy for Organ-confined Prostate Cancer: Feasibility & Early Results. Intern J Radiat Oncol Biol Phys 75(3):S334, 2009
Meier R, Mehta V, Vermeulen S, Young R. Dose-response and dose-complication relationships in stereotactic radiosurgery for trigeminal neuralgia. Intern J Radiat Oncol Biol Phys. 60(1): S547, 2004
Meier R, Hatton J, Mehta V. Forward-planning breast IMRT: early clinical experience. Intern J Radiat Oncol Biol Phys. 57(2): S368, 2003
Meier R, Brawer M. Selecting treatment for high-risk, localized prostate cancer: the case for radiation therapy. Reviews in Urology. 4(3); 141-46, 2002
Meier R, Mark R, St. Royal L, Tran L, Colburn G, Parker R. Postoperative radiotherapy following radical prostatectomy for prostate carcinoma. Cancer. 1992; 70:1960-1966.
Book Editor:
Posnsky L, Fuller D, Meier R, Ma C (Editors): Treating Prostate Cancer and Related Genitourinary Applications. New York: Springer-Verlag, 2012.
Other publications
Vermeulen S, Cotrutz C, Morris A, Meier R, Buchanan C, Dawson P, Porter B. Accelerated (partial breast irradiation: using the CyberKnife as the radiation delivery platform in the treatment of early breast cancer. Front. Oncol. 1:43, 2001.
Young RF, Li F, Vermeulen S, Meier R, Gamma Knife thalamotomy for treatment of essential tremor: long-term results. J Neurosurg. 2009 Nov 6.
Sylvester J, Blasko J, Grimm P, Meier R, Malmgren J. Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience. Intern J Radiat Oncol Biol Phys. 57(4): 944-52, 2003
Grimm P, Blasko J, Sylvester J, Meier R, Cavanagh W. Ten-year biochemical (prostate- specific antigen) control of prostate cancer with 125-I brachytherapy. Intern J Radiat Oncol Biol Phys. 51(1): 31-40, 2001
Sylvester J, Grimm P, Blasko J, Meier R, Spiegel J, Heaney C, Cavanagh W. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns or urologists and radiation oncologists in the United States. Urology. 58(2 suppl 1):65-70, 2001.
Grimm P, Blasko J, Sylvester J, Cavanagh W, Meier R. Ten year biochemical outcomes following 125-iodine monotherapy for early stage prostate cancer. Intern J Radiat Oncol Biol Phys. 48(3): 146-147, 2000.
Sylvester J, Blasko J, Grimm P, Meier R, Cavanagh W. Short-course androgen ablation combined with external-beam radiation therapy and low-dose-rate brachytherapy in early-stage prostate cancer: a matched subset analysis. Molecular Urology. 4(3):155-59, 2000
Vermeulen S, Young R, Li F, Meier R, Raisis J, Klein S, Kohler E. Comparison of single fraction radiosurgery tumor control and toxicity in the treatment of basal and nonbasal meningiomas. Stereotact & Funct Neurosurg. 72(suppl. 1): 60-66, 1999.
Sylvester J, Blasko J, Grimm P, Meier R, Colburn G, Goy B, Cavanagh W. Neoadjuvant androgen ablation combined with exernal beam radiotherapy and brachytherapy in early stage prostate cancer. Molecular Urology. 1999; 3:231-238.
Tran L, Mark R, Meier R, Calcaterra T, Parker R. Sarcomas of the head and neck: Prognostic factors and treatment strategies. Cancer. 1992; 70:169-177.
PRESENTATIONS : National Meetings
Patient-Reported Quality of Life Outcomes in Intermediate-Risk Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy. 54thAnnual Meeting of the American Society for Therapeutic Radiation Oncology, September 2013, Atlanta, Georgia
Stereotactic Body Radiation Therapy for Intermediate-risk Organ-confined Prostate Cancer: Interim Toxicity and Quality of Life Outcomes from a Multi-Institutional Study. 53rd Annual Meeting of the American Society for Therapeutic Radiation Oncology, October 2012, Boston, Massachusetts
Stereotactic Radiotherapy for Organ-confined Prostate Cancer: Early Toxicity and Quality of Life Outcomes from a Multi-institutional Trial. 52nd Annual Meeting of the American Society for Therapeutic Radiation Oncology, November 2010, San Diego, California
Radiosurgery for Organ-confined Prostate Cancer: Early Toxicity Outcomes from a Multi- institutional Trial. 105th Annual Meeting of the American Urologic Association, June 2, 2010, San Francisco, California
MRI-Planned Stereotactic Body Radiotherapy for Organ-Confined Prostate Cancer: Feasibility and Early Results. 51st Annual Meeting of the American Society for Therapeutic Radiation Oncology, November 2009, Chicago, Illinois
Stereotactic body radiotherapy for organ-confined prostate cancer: Feasibility and early results. Presented at the 91st Annual Meeting of the American Radium Society, April 2009.
Dose-response and dose-complication relationships in stereotactic radiosurgery for trigeminal neuralgia. Presented at the 46th Annual Meeting of the American Society for Therapeutic Radiation Oncology, October, 2004, Atlanta, Georgia
Forward-planning breast IMRT: early clinical experience. Presented at 45th Annual Meeting of the American Society for Therapeutic Radiation Oncology, October 2003, Salt Lake City Utah
Acute genitourinary complications of permanent interstitial prostate brachytherapy,
presented at the Annual Meeting of the Radiologic Society of North America, November 1999.
Postoperative radiation therapy for pathologic stage C prostate carcinoma, presented at the 71st Annual Meeting of the American Radium Society, April 1989.
ADDITIONAL EXPERIENCE :
CyberKnife Radiotherapy, Swedish Radiosurgery Center (Swedish Hospital)
Stereotactic radiosurgery using the Gamma Knife, for intracranial neoplasias and functional Disorders, Swedish Radiosurgery Center (Swedish Hospital)
Permanent transperineal prostate brachytherapy (Seattle Prostate Institute, Swedish Cancer Institute, and Southwest Tumor Institute)
Temporary transperineal prostate brachytherapy (HDR, Swedish Hospital; LDR training at California Endocurietherapy and Long Beach Memorial Medical Center)
Interstitial and intracavitary brachytherapy for gynecologic and head and neck malignancies, Stanford Hospital and Kaiser Santa Clara Hospital
Intravascular coronary brachytherapy to prevent restenosis (Swedish Hospital) Intraoperative radiotherapy (orthovoltage unit, Stanford University Hospital) Externally applied hyperthermia (Palo Alto Medical Foundation)
ADDITIONAL PROFESSIONAL ACTIVITIES & MEMBERSHIPS :
American Society for Therapeutic Radiology and Oncology Member, Board of Directors, Radiation Therapy Innovations